Literature DB >> 32155016

Taurine induces autophagy and inhibits oxidative stress in mice Leydig cells.

Shokofeh Yahyavy1,2, Armita Valizadeh2, Ghasem Saki2, Layasadat Khorsandi1,2.   

Abstract

OBJECTIVES: This study evaluated taurine (TAU) effects on autophagy, apoptosis and oxidative stress in mice Leydig TM3 cells.
METHODS: We treated TM3 cells with TAU (100 µg/mL) or 3-Methyladenine (3-MA, an autophagy inhibitor) for 24 h, and assessed cell viability, testosterone level, oxidative stress, apoptosis, and autophagy.
RESULTS: The results showed that TAU markedly increased cell viability, testosterone levels, expression of autophagy-related genes and percentage of LC3-II-positive cells. TAU significantly reduced malondialdehyde (MDA) contents and reactive oxygen species (ROS) levels and increased the activities of SOD (superoxide dismutase) and CAT (Catalase) enzymes in the TM3 cells. TAU in the presence of autophagy inhibitor (3-MA) increased oxidative stress and decreased testosterone levels.
CONCLUSION: The results showed that autophagy might be involved in TAU-increased testosterone levels in mice Leydig TM3 cells.

Entities:  

Keywords:  Leydig cells; autophagy; oxidative stress; taurine; testosterone

Year:  2020        PMID: 32155016      PMCID: PMC7365531          DOI: 10.5935/1518-0557.20190079

Source DB:  PubMed          Journal:  JBRA Assist Reprod        ISSN: 1517-5693


INTRODUCTION

Taurine (TAU) is a free amino acid that is present in several mammalian tissues (De Luca ; Park ; Yang ). TAU is present in some foodstuff, such as fish and meat and often added to energy drinks. TAU has several physiological functions including energy storage, membrane stabilization, antioxidation and xenobiotic conjugation (Huxtable, 1992). In male reproductive organs, TAU is present in Leydig cells, and in some other cells (Yang ). Lobo reported that TAU stimulated testosterone secretion in vivo and in vitro. Despite its importance, we still do not know the impact of TAU in Leydig cells. Leydig cells produce testosterone in testicular tissues, where autophagy is active (Yi & Tang, 1999). In autophagy, microtubule-associated protein-1 light chain (LC3-I) converts to a lipid form, termed LC3-II, by a complex of Atg5, Atg12, and Atg16 proteins to induce autophagosome. Mammalian rapamycin (mTOR) regulates autophagy by activating several autophagy-related proteins, including Beclin-1, Atg1, Atg5, and Atg7 (He & Klionsky, 2009). Autophagy regulates ROS buildup by increasing the clearance of damaged organelles and activating antioxidant enzymes in the Leydig cells (Li ). In the present study we investigated the TAU effect on oxidative stress, autophagy, apoptosis, and testosterone level in the mouse Leydig TM3 cells.

MATERIALS AND METHODS

Experimental design

The mice Leydig TM3 cell line was bought through the National Center for Genetic and Biological Reserves in Iran. We cultured the cells in DMEM medium, complemented with 10% fetal bovine serum and 1% penicillin/streptomycin at 37ºC within a moist atmosphere with 5% CO2. The cells were incubated with TAU (Sigma) at various concentrations for 12, 24, 48 and 72h, as a pilot study (Table 1). The cells were grouped into 4 categories (Figure 1):
Table 1

Viability percentage in TM3 cells at different doses and duration times of TAU treatment (pilot study).

Treatments12 h24 h4872
12.5µg/mL99.4 ± 4.598.7 ± 4.798.6 ± 2.2100.4 ± 3.2
25 µg/mL98.3 ± 4.8101.5 ± 3.2102.2 ± 5.3102.6 ± 5.1
50 µg/mL99.2 ± 3.5105.7 ± 6.9105.6 ± 4.2104.3 ± 6.4
100 µg/mL98.6 ± 5.5135.2 ± 11.2*138.1 ± 9.3*132.8 ± 9.8*
150 µg/mL98.8 ± 4.3136.4 ± 12.2*137.3 ± 10.7*134.6 ± 12.3*
200 µg/mL99.2 ± 3.6136.7 ± 10.7*137.8 ± 11.3*135.1 ± 10.7*

Values are expressed as mean ± SD (n=6).

p<0.05 *symbol indicates comparison to 12h in each row

Figure 1

Schematic illustration of the study design

Viability percentage in TM3 cells at different doses and duration times of TAU treatment (pilot study). Values are expressed as mean ± SD (n=6). p<0.05 *symbol indicates comparison to 12h in each row Schematic illustration of the study design Control: received only media for 24h 3-MA (3-Methyladenine, an autophagy inhibitor): received 10 mmol 3-MA for 24h TAU: received 100 µg/mL TAU for 24h TAU + 3-MA: received 10 mmol 3-MA and 100 µg/mL TAU for 24h

Cell viability

We cultured the TM3 (1 × 104 cells/well) cells in 96-well plates. After treating them, the supernatants were disposed of and we added 20 µL of MTT solution (5 mg/ml) to all of the wells and incubated for four hours at 37ºC. Upon completion of incubation, the medium was eliminated, and we added 100 µL of DMSO to all of the wells. We used a micro-plate reader (BioRad, USA) to measure absorbance at 570 nm.

Testosterone assay

We incubated the cell suspensions with TAU or 3-MA in the presence of hCG (0.05IU/ml) at 37ºC for 24h. We measured the testosterone concentration in culture media via a radio-immunoassay, complying with the manufacturer`s guidelines (Monobind, USA).

Annexin V-FITC/propidium iodide apoptosis assay

We seeded the TM3 cells (1.0×106/mL) in a six-well culture plate, and normal, apoptotic and necrotic cells were distinguished using an Annexin V-FITC/propidium iodide assay kit (Ebioscience™ Annexin V Kit, USA) according to the manufacturer’s instruction. We analyzed the samples using a flow cytometer (BD Facscalibur, USA). We analyzed the data using the FlowJo V10.

Immunocytochemistry

After treating the TM3 cells, we deposited them over a glass coverslip and let it stabilize for fifteen minutes in a 4% para-formaldehyde in PBS at 4ºC. Then, we washed them in PBS. We used anti-LC3-II antibody (sc-16755, Santa Cruz) at 1/100 dilution overnight at 4ºC. After washing twice in PBS, we incubated the section with FITC-conjugated anti-mice secondary anti-body (sc-2356, Santa Cruz) for one hour at room temperature. The fluorescence pictures were captured by a fluorescence microscope (Olympus, Japan).

Real-Time Polymerase Chain Reaction

The whole RNA was drawn out from the cells via the RNeasy Mini kit (Qiagen) in accordance with the Company's guidelines. We synthesized cDNA using a cDNA synthesis kit from total RNA regarding the manufacturer's instruction. About 2 µL of cDNA boosted in each 25 µL PCR reaction mix, which contains 10.1 µl DEPC water, 0.2 µL of each 10pM forward and reverse primers, and 12.5 µL of 2x SYBR Green Master Mix [Fermentas, Canada] (Table 2). PCR was amplified in forty cycles through this protocol: 95ºC for ten minutes, 95ºC for fifteen seconds, 95ºC for thirty seconds, and 60ºC for thirty-four seconds. We used the 2ΔΔCT method to analyze the data.
Table 2

Primer sequences.

Groups Forward Reverse
Bax GCTGGACATTGGACTTCCTCACCACTGTGACCTGCTCCA
Bcl-2 GGATGCCTTTGTGGAACTGTTCACTTGTGGCCCAGATAGG
Beclin-1 CGGTTTTTCTGGGACAACAAAAAAACGTGTCTCGCCTTTC
mTOR  TATTCACCTCCTGCCTCACCTGTGATGGCTGTGAAGATCC
Atg5 CCAGAAAAAGACCTTCTGCACTCAATCCCATCCAGAGTTGCT
LC3-II GATAATCAGACGGCGCTTGCACTTCGGAGATGGGAGTGGA
GAPDH ACCCAGAAGACTGTGGATGGTTCTAGACGGCAGGTCAGGT
Primer sequences.

Determining MDA content, ROS level and anti-oxidant enzyme activity

We treated the TM3 cells with TAU or 3-MA for 24h. Afterwards, we performed the lysis of the gathered specimens, and the protein contents of the TM3 cells we identified via a BCA protein assay kit (Pierce Biotechnology Inc. IL). Upon having the cell lysates centrifuged, we assessed the contents of malondialdehyde (MDA), Catalase (CAT), and super-oxide dismutase (SOD) activity on the basis of the related guidelines (ZellBio, GmbH, Germany). With regards to the Company's guidelines, we measured the reactive oxygen species (ROS) using a dichloro-dihydrofluorescein diacetate (DCFH-DA) determination kit (Sigma, St. Louis, MO). We measured the ROS via a spectrofluorometer (LS50B, Waltham, USA; Ex: 490 nm, Em: 570 nm).

Statistical analyses

We used the ANOVA SPSS 21.0 (Chicago, IL, USA) to analyze the data. Then, we carried out a post-hoc pair-wise comparison using the Bonferroni technique. We considered the p value ˂0.05 as statistically significant. Each experiment were done in quadruplicates.

RESULTS

The cell viability percentage significantly decreased in 3-MA exposed TM3 cells, compared to the control cells (p<0.05). The cell viability significantly increased in TAU-treated cells, compared to the control cells (p<0.05). In the TAU + 3-MA group, the cell viability of TM3 cells significantly decreased in comparison with the TAU and 3-MA groups (Figure 2).
Figure 2

Morphology (above images) and viability (the following pictures) of TM3 cells in experimental and control groups (Scale bar: 100 µm). The arrows indicate apoptotic morphology. The values are expressed as mean ± SD. *p<0.05, # p<0.05, $ p<0.05; *, # and the $ symbols respectively indicate comparison to the control, 3-MA and TAU groups.

Morphology (above images) and viability (the following pictures) of TM3 cells in experimental and control groups (Scale bar: 100 µm). The arrows indicate apoptotic morphology. The values are expressed as mean ± SD. *p<0.05, # p<0.05, $ p<0.05; *, # and the $ symbols respectively indicate comparison to the control, 3-MA and TAU groups. The testosterone level significantly decreased in 3-MA exposed TM3 cells when compared to the control cells (p<0.05). The testosterone concentration significantly increased in TAU-treated cells, compared to the control and 3-MA groups (p<0.01). In the TAU + 3-MA group, the testosterone level of the TM3 cells significantly decreased in comparison with the TAU-treated cells (Figure 3).
Figure 3

Testosterone concentration in the control and experimental groups. The arrows indicate apoptotic morphology. The values are expressed as mean ± SD. *p<0.05, **P<0.01, # p<0.05, ## p<0.01, $ p<0.05; *, # and the $ symbols respectively indicates comparison to the control, 3-MA and TAU groups.

Testosterone concentration in the control and experimental groups. The arrows indicate apoptotic morphology. The values are expressed as mean ± SD. *p<0.05, **P<0.01, # p<0.05, ## p<0.01, $ p<0.05; *, # and the $ symbols respectively indicates comparison to the control, 3-MA and TAU groups. In 3-MA exposed TM3 cells, necrotic and apoptotic indices were significantly higher than those from control cells. TAU decreased the late apoptosis, necrosis, and early apoptosis percentages in TM3 cells in comparison with the control and 3-MA groups (p<0.01). In the TAU + 3-MA group, the apoptotic and necrotic indices significantly increased in comparison with TAU-treated cells (Figure 4), and significantly reduced when compared to the 3-MA-treated cells.
Figure 4

Flow cytometry of Annexin / PI staining in the experimental & control groups. Lower left quadrant: live cells; Lower right quadrant: initial apoptosis; Upper right quadrant: late apoptosis; Upper left quadrant: necrotic cells (A and B). The relative level of mRNA expression of Bax and Bcl-2 genes and Bax/Bcl-2 ratio (C and D). The values are expressed as mean±SD. *p<0.05, **p<0.01, # p<0.05, ## p<0.01, ### p<0.001, $ p<0.05, $$ p<0.01; *, # and the $ symbols respectively indicate comparison to the control, 3-MA and TAU groups.

Quantitative Real-time RT-PCR

In 3-MA exposed TM3 cells, the expression of Bax and Bcl-2 considerably changed in comparison to the control group. In the TAU-treated cells, the expression of the Bax was considerably higher, while the expression of the Bcl-2 significantly diminished compared to the control and 3-MA groups. There was a significant increase in the expression of the Bax gene while there was a significant reduction in the expression of the Bcl-2 gene in TAU+3-MA-treated cells, compared with the controls and TAU-treated cells (Figure 4). In 3-MA exposed TM3 cells, the Bax/Bcl-2 ratio significantly increased in comparison with the control group. In the TAU-treated cells, the Bax/Bcl-2 ratio significantly decreased compared to the control and 3-MA groups. The Bax/Bcl-2 ratio significantly increased, compared with the control and TAU-treated cells (Figure 4). Flow cytometry of Annexin / PI staining in the experimental & control groups. Lower left quadrant: live cells; Lower right quadrant: initial apoptosis; Upper right quadrant: late apoptosis; Upper left quadrant: necrotic cells (A and B). The relative level of mRNA expression of Bax and Bcl-2 genes and Bax/Bcl-2 ratio (C and D). The values are expressed as mean±SD. *p<0.05, **p<0.01, # p<0.05, ## p<0.01, ### p<0.001, $ p<0.05, $$ p<0.01; *, # and the $ symbols respectively indicate comparison to the control, 3-MA and TAU groups. In 3-MA-treated cells, the LC3-II, Atg5 and Beclin1 genes were not expressed while the mTOR expression was significantly higher. In TAU-treated cells, the mTOR gene expression was significantly reduced while the expression of the LC3-II, Atg5 and Beclin1 genes experienced a significant increase, compared to that of control cells. In TAU+3-MA-treated cells, the mTOR expression showed a significant increase in comparison with those from the TAU-treated cells. While there was a significant reduction in mTOR expression in comparison with 3-MA-treated cells (Figure 5).
Figure 5

Immunofluorescent microscopy of the TM3 cells, percentage of LC3-II-positive cells and expression of autophagy-related genes. The bright green staining indicates LC3-II-positive cells (scale bars: 100 µm). The values are expressed as mean±SD; *p<0.05, **p<0.01, #p<0.05, ##p<0.01, $p<0.05; *, # and the $ symbols respectively indicate comparison to the control, 3-MA and TAU groups.

Immunofluorescent microscopy of the TM3 cells, percentage of LC3-II-positive cells and expression of autophagy-related genes. The bright green staining indicates LC3-II-positive cells (scale bars: 100 µm). The values are expressed as mean±SD; *p<0.05, **p<0.01, #p<0.05, ##p<0.01, $p<0.05; *, # and the $ symbols respectively indicate comparison to the control, 3-MA and TAU groups. In the 3-MA exposed TM3 cells, we did not detect LC3-II. There was a significant increase of the percentage of LC3-II-positive cells in comparison with control group (p<0.05) by TAU (p<0.05). Figure 5 depicts these results.

ROS levels, MDA content and antioxidant enzyme activity

ROS level and MDA content of 3-MA exposed cells were significantly increased in comparison with those from the control group. There was a considerable reduction in MDA contents and levels of ROS in the TAU-treated cells when compared to the 3-MA and control groups (p<0.05). In the TAU+3-MA, the ROS level and MDA content significantly changed in comparison with the TAU and 3-MA groups. In the 3-MA exposed cells, CAT and SOD activity significantly decreased in comparison with the control group. In the TAU-treated cells, the antioxidant activity significantly increased in comparison with the 3-MA and control groups (p<0.05). In the TAU+3-MA, the CAT and SOD activity significantly changed in comparison with the TAU and 3-MA groups (Figure 6).
Figure 6

MDA contents, levels of ROS (DCF formations) and activities of the anti-oxidant enzyme in the experimental and control groups. The values were expressed as mean ±SD. *p<0.05, #p<0.05, ##p<0.01, $p<0.05; *, # and the $ symbols respectively indicate comparison to the control, 3-MA and TAU groups

MDA contents, levels of ROS (DCF formations) and activities of the anti-oxidant enzyme in the experimental and control groups. The values were expressed as mean ±SD. *p<0.05, #p<0.05, ##p<0.01, $p<0.05; *, # and the $ symbols respectively indicate comparison to the control, 3-MA and TAU groups

DISCUSSION

The present study showed that TAU increased the levels of testosterone, improved antioxidant activity, decreased ROS levels, inhibited apoptosis, and induced autophagy in TM3 Leydig cells. The results show that TAU could increase the viability percentage of TM3 cells. The increasing viability may be associated with the increasing survival of TM3, but not for the proliferation of these cells. Indeed, flow cytometry and morphology evaluations showed that TAU markedly reduced apoptosis in TM3 cells. TAU decreased the Bax/Bcl-2 ratio in the TM3 cells, also showing suppression of apoptosis. Previous studies have also reported anti-apoptotic effects of TAU in noncancerous cells (Takatani ; Kim ; Das ). Aly & Khafagy (2014) showed anti-apoptotic effects of TAU against endosulfan in adult rat testicles. TAU inhibited apoptosis in Thiopurine-induced testicular damages in rats (Ramadan ). The expression of autophagy-related genes including Beclin-1, Atg5, and LC3-II was markedly increased in the TAU-treated cells. The percentage of LC3-II-positive cells also increased in the TAU-treated cells. Kaneko reported that TAU could induce autophagy in adipocytes. In the presence of 3-MA, TAU increased the Bax/Bcl-2 ratio in comparison with the absence of 3-MA, indicating that TAU may suppress apoptosis by enhancing the autophagy process. 3-MA in the presence of TAU decreased the apoptotic index of TM3 cells, in comparison with the absence of TAU. This finding indicated that TAU could also suppress apoptosis by involving multiple signaling pathways. In the current study, testosterone levels dramatically increased in the TAU-treated cells, which may be associated with the increasing viability of TM3 cells or the increasing biosynthesis of androgens. Yang showed that TAU could stimulate testosterone generation in cultured Leydig cells. The reducing testosterone level in 3-MA- treated cells indicated autophagy involved in testosterone production in the TM3 cells. Rapamycin (autophagy stimulator) induced an increase in testosterone concentration in rat Leydig cells, whereas 3-MA had the opposite effect (Yang ). Gao revealed that autophagy increased cholesterol absorption by the Leydig cells and dysfunction of autophagy leads to insufficient testosterone production. Autophagy activity decreased in aged rat Leydig cells (Li ), and testosterone levels reduced in autophagy deficiency in mice (Yoshii ). The autophagy inhibition was accompanied by a massive loss of germ cells (González ). By contrast, Zhang showed that heat exposure caused autophagy-induced germ cell death and spermatogenesis defects in mice. In presence of TAU, 3-MA induced a marked increase in testosterone levels in comparison with the absence of TAU. Thus, other mechanisms may also activate testosterone production by TAU. TAU increases testosterone levels and raises testicular antioxidation in diabetic rats (Liu ). In the present study, TAU suppressed oxidative stress by reducing MDA content and ROS levels, and increasing antioxidant enzyme activity. TAU could prevent lipid peroxidation in rabbit sperm (Alvarez & Storey, 1983). TAU reversed SOD activity in oxidative stress induced by cadmium or arsenic (Sinha ; Das . Higuchi found that TAU enhanced SOD activity in the eel testicular tissue. TAU prevented apoptosis and oxidative stress induced by doxorubicin in rat testicles (Das ). Reducing cell death by TAU may relate to inhibition of oxidative stress in TM3 cells. ROS generation can stimulate apoptosis signaling pathways (Redza-Dutordoir & Averill-Bates, 2016). Oxidative stress can induce apoptosis in Leydig cells (Wang ).

CONCLUSIONS

In summary, this study showed that TAU induces autophagy and suppresses apoptosis in TM3 cells. This increasing autophagy is accompanied by increasing testosterone levels and reducing oxidative stress.
  25 in total

1.  The convergent point of the endocytic and autophagic pathways in leydig cells.

Authors:  J Yi; X M Tang
Journal:  Cell Res       Date:  1999-12       Impact factor: 25.617

Review 2.  Physiological actions of taurine.

Authors:  R J Huxtable
Journal:  Physiol Rev       Date:  1992-01       Impact factor: 37.312

3.  Taurine is an amino acid with the ability to activate autophagy in adipocytes.

Authors:  Hiroki Kaneko; Masaki Kobayashi; Yuhei Mizunoe; Maho Yoshida; Hiromine Yasukawa; Shunsuke Hoshino; Rei Itagawa; Takuma Furuichi; Naoyuki Okita; Yuka Sudo; Masato Imae; Yoshikazu Higami
Journal:  Amino Acids       Date:  2018-03-09       Impact factor: 3.520

4.  Taurine protects rat testes against doxorubicin-induced oxidative stress as well as p53, Fas and caspase 12-mediated apoptosis.

Authors:  Joydeep Das; Jyotirmoy Ghosh; Prasenjit Manna; Parames C Sil
Journal:  Amino Acids       Date:  2011-04-08       Impact factor: 3.520

5.  Inhibition of apoptosis by taurine in macrophages treated with sodium nitroprusside.

Authors:  So Young Kim; Taesun Park; Ha Won Kim
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

6.  Taurine protects the antioxidant defense system in the erythrocytes of cadmium treated mice.

Authors:  Mahua Sinha; Prasenjit Manna; Parames C Sil
Journal:  BMB Rep       Date:  2008-09-30       Impact factor: 4.778

7.  Taurine, hypotaurine, epinephrine and albumin inhibit lipid peroxidation in rabbit spermatozoa and protect against loss of motility.

Authors:  J G Alvarez; B T Storey
Journal:  Biol Reprod       Date:  1983-10       Impact factor: 4.285

Review 8.  Taurine: the appeal of a safe amino acid for skeletal muscle disorders.

Authors:  Annamaria De Luca; Sabata Pierno; Diana Conte Camerino
Journal:  J Transl Med       Date:  2015-07-25       Impact factor: 5.531

9.  The balance between apoptosis and autophagy regulates testis regression and recrudescence in the seasonal-breeding South American plains vizcacha, Lagostomus maximus.

Authors:  Candela R González; María L Muscarsel Isla; Alfredo D Vitullo
Journal:  PLoS One       Date:  2018-01-31       Impact factor: 3.240

10.  Autophagy regulates testosterone synthesis by facilitating cholesterol uptake in Leydig cells.

Authors:  Fengyi Gao; Guoping Li; Chao Liu; Hui Gao; Hao Wang; Weixiao Liu; Min Chen; Yongliang Shang; Lina Wang; Jian Shi; Wenlong Xia; Jianwei Jiao; Fei Gao; Jian Li; Liang Chen; Wei Li
Journal:  J Cell Biol       Date:  2018-04-04       Impact factor: 10.539

View more
  3 in total

1.  Downregulation of miR-200a Protects Mouse Leydig Cells Against Triptolide by Triggering Autophagy.

Authors:  Hui Miao; Congxiu Miao; Jing Han; Na Li
Journal:  Drug Des Devel Ther       Date:  2020-11-10       Impact factor: 4.162

2.  The modulatory effect of taurine on benzo (a) pyrene-induced hepatorenal toxicity.

Authors:  Solomon E Owumi; Gideon Adeniyi; Adegboyega K Oyelere
Journal:  Toxicol Res (Camb)       Date:  2021-04-12       Impact factor: 3.524

3.  Protective role of taurine against oxidative stress (Review).

Authors:  Stella Baliou; Maria Adamaki; Petros Ioannou; Aglaia Pappa; Mihalis I Panayiotidis; Demetrios A Spandidos; Ioannis Christodoulou; Anthony M Kyriakopoulos; Vassilis Zoumpourlis
Journal:  Mol Med Rep       Date:  2021-06-29       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.